IL-33 levels were increased in patients with disease associated with chronic inflammation such as ankylosing spondylitis [10], rheumatoid arthritis [11], Henoch-Schonlein purpura [12], or multiple sclerosis [13]. Here, IL33 is linked to Henoch-Schoenlein purpura.